查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
促红细胞生成素药品市场:按类型、按产品、按应用、按国家、按地区 - 行业分析、市场规模、市场份额、预测 2023-2030
市场调查报告书
商品编码
1299748

促红细胞生成素药品市场:按类型、按产品、按应用、按国家、按地区 - 行业分析、市场规模、市场份额、预测 2023-2030

Erythropoietin Drugs Market with COVID-19 Impact Analysis, By Type, By Product, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 358 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年促红细胞生成素製剂市场规模将达到 70.81 亿美元，2023 年至 2030 年復合年增长率为 10.5%

促红细胞生成素市场 - 市场动态:

终末期肾病治疗、抗逆转录病毒治疗和化疗引起的贫血症患病率不断增加，预计是增加促红细胞生成素市场需求的主要因素。 此外，除了治疗贫血之外，重组人促红细胞生成素还具有多种治疗优势，例如在脑部疾病方面。 此外，全身施用促红细胞生成素可以通过跨越血脑屏障来改善神经可塑性并增强许多脑部疾病的认知功能。 然而，促红细胞生成素製剂的成本上升是预测期内限制市场增长的主要因素之一。

此外，人们对促红细胞生成素製剂益处的认识提高、易于获得的报销以及促红细胞生成素生物仿製药的商业化趋势不断上升，预计将推动 EPO 治疗市场的增长。 COVID-19 大流行对促红细胞生成素市场产生了积极影响。 对药品的需求增加了，对各种医疗服务的需求也增加了。 此外，据说该药物有助于治疗贫血，并且对 COVID-19 有效。

促红细胞生成素药物市场 - 细分分析:

全球促红细胞生成素市场按类型、产品、应用和地区细分。

生物製药和生物仿製药分为两类。 生物仿製药领域可能会主导市场。 其原因包括强大的产品线、製造商和医院之间合作关係的加强以及研发资金的增加。

市场按产品分为两类:促红细胞生成素和达贝泊汀-ALPHA。 达贝泊汀-ALPHA製剂预计将主导市场。 部分原因是达贝泊汀-ALPHA有助于治疗接受癌症化疗的患者发生的贫血。

根据应用，市场分为三类:肿瘤学、肾臟疾病、神经病学和其他。 据估计，在预测期内，癌症细分市场将占据最大的市场份额。 由于酒精、西方生活方式、吸烟和不良饮食习惯，癌症患者不断增加。 因此，它将推动肿瘤学领域的增长。

促红细胞生成素市场 - 竞争格局:

对促红细胞生成素製剂的需求不断增长推动了全球市场的增长。 此外，市场参与者还关注新产品发布、合作伙伴关係、合资企业、联盟和区域增长。 此外，癌症患者贫血的增加正在推动促红细胞生成素市场的增长。 此外，市场参与者用于加强和扩展业务的策略包括研发支出、併购和市场开发。 例如，2022 年 3 月，Zydus Lifesciences 获得了治疗 Oxemia（Desidustat）的新药批准。 它还获得印度药品监管局 (DCGI) 批准，作为第一种治疗慢性肾病 (CKD) 相关贫血的口服药物。

研究的主要特点

本研究报告提供了促红细胞生成素市场的市场规模、复合年增长率、估计和预测（2023-2030），并以 2022 年为基准年。

本研究报告阐明了不同细分市场/国家的潜在增长机会，并概述了促红细胞生成素市场有吸引力的投资主张矩阵。

总体报告确定了新的投资机会、现有企业面临的挑战以及促红细胞生成素市场可持续发展的增长动力。

研究范围详细讨论了 COVID-19 对促红细胞生成素市场规模、预测、复合年增长率和市场动态的影响。 它还涵盖了对新冠疫情后促红细胞生成素市场的详细见解。

为了向本报告的用户提供促红细胞生成素市场的全面了解，我们还对促红细胞生成素市场进行了竞争格局和关键创新者分析。

该研究涵盖了基于市场规模、增长率和吸引力对所有行业领域进行基准测试的增长前景映射分析。

该报告提供了主要市场参与者的详细公司概况，以帮助您了解在促红细胞生成素市场运营的公司的财务信息和战略举措。

此外，报告还揭示了全球和区域市场主要参与者的重大收购和合併、合作和合资企业、初创企业、研发和区域扩张。

全球促红细胞生成素製剂市场报告主要面向该行业的各个利益相关者，包括供应商、投资者、新进入者、分销商和财务分析师。

内容

第一章促红细胞生成素市场概述

  • 调查范围

第 2 章执行摘要

  • 市场细分
  • 竞争考虑因素

第三章促红细胞生成素製剂主要市场趋势

  • 促红细胞生成素製剂市场驱动因素
  • 促红细胞生成素药物市场製约因素
  • 促红细胞生成素製剂的市场机会
  • 促红细胞生成素药物市场的未来趋势

第四章促红细胞生成素医药行业调查

  • PEST分析
  • 波特五力分析
  • 增长前景图
  • 监管框架分析

第五章促红细胞生成素市场:COVID-19 的影响分析

  • 新冠肺炎 (COVID-19) 疫情之前的影响分析
  • 新冠肺炎 (COVID-19) 疫情后影响分析

第六章促红细胞生成素市场状况

  • 2022 年促红细胞生成素製剂市场份额分析
  • 主要製造商的详细数据
    • 现有公司分析
    • 初创企业分析

第 7 章促红细胞生成素市场 - 按类型

  • 概述
    • 按类型划分的细分市场份额分析
    • 生物製剂
    • 生物仿製药

第 8 章促红细胞生成素市场 - 按产品

  • 概述
    • 按产品划分的细分市场份额分析
    • 促红细胞生成素
    • 达贝泊汀阿尔法

第 9 章促红细胞生成素市场 - 按应用

  • 概述
    • 按应用划分的细分市场份额分析
    • 癌症
    • 肾臟疾病
    • 神经病学
    • 其他

第 10 章促红细胞生成素市场 - 按地区

  • 简介
  • 北美
    • 概述
    • 北美促红细胞生成素製剂主要生产商
    • 美国
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲促红细胞生成素製剂的主要製造商
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 其他
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区主要促红细胞生成素製剂生产商
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印度尼西亚
    • 菲律宾
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲促红细胞生成素製剂的主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他
  • 中东和非洲
    • 概述
    • 中东和非洲促红细胞生成素製剂的主要製造商
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他

第十一章主要供应商分析-促红细胞生成素製药行业

  • 竞赛仪表板
  • 公司简介
    • AstraZeneca（UK）
    • Lupin（India）
    • Bristol-Myers Squibb Company（US）
    • Endo International plc（Ireland）
    • JCR Pharmaceuticals Co., Ltd（Japan）
    • Pfizer Inc（US）
    • Teva Pharmaceutical Industries Ltd（Israel）
    • Sun Pharmaceutical Industries Ltd（India）
    • Dr. Reddy's Laboratories Ltd（India）
    • Mylan NV（US）
    • Novartis AG（Switzerland）
    • Cipla Inc（India）
    • Shanghai Dahua Pharmaceutical Co., Ltd（China）

第十二章分析师的全面观点

Product Code: ANV1338

REPORT HIGHLIGHT

Erythropoietin drugs market size was valued at USD 7,008.1 Million in 2022, expanding at a CAGR of 10.5% from 2023 to 2030.

Erythropoietin (EPO) is also known as hematopoietin, a glycoprotein hormone secreted from the kidneys that play an important role in the development of red blood cells (RBCs) in the bone by stimulating the bone marrow tissues. Additionally, a rise in RBC count increases the hemoglobin level in the bloodstream and delivers a sufficient amount of oxygen to every part of the body. Moreover, erythropoietin medications are largely used in the treatment of anemia caused by end-stage renal disease (ESRD) and dialysis procedures.

Erythropoietin Drugs Market- Market Dynamics:

The increasing prevalence of anemic conditions caused by ESRD treatment, antiretroviral treatment, and chemotherapy are major factors projected to increase the demand for the erythropoietin market. Additionally, besides treating anemia, several therapeutic advantages are associated with recombinant human erythropoietin such as brain disorders. Moreover, if erythropoietin is administered systematically, it passes the blood-brain barrier as a result improving neuroplasticity and rising cognitive functions in many brain disorders. However, the increasing cost of erythropoietin drugs is one of the major factors that could restrain the market growth during the forecast period.

Furthermore, increasing awareness regarding the advantages of erythropoietin therapeutics drugs, readily available reimbursements, and rising trends of commercialization for erythropoietin biosimilars are expected to boost the EPO drugs market growth. The COVID-19 pandemic had a positive impact on the erythropoietin drugs market. It increased the demand for medicines and also increased the demand for various medical services. Additionally, the drug is helpful in anemia treatment and works against COVID-19.

Erythropoietin Drugs Market- Segmentation Analysis:

The global erythropoietin drugs market is segmented on the basis of type, product, application, and region.

The market is divided into two categories based on type: biologics and biosimilars. The biosimilars sector is likely to dominate the market. Due to the strong product pipeline, an increasing partnership among manufacturers & hospitals, and rising funds for development & research.

The market is divided into two categories based on product: erythropoietin and darbepoetin-alfa. The darbepoetin-alfa sector is expected to possess the market. This is partially due to darbepoetin-alfa helping in treating anemia that occurs in a patient who received chemotherapy for cancer.

The market is divided into three categories based on application: cancer, renal diseases, neurology, and others. The cancer sector is estimated to hold the largest market share during the forecast period. Cancer cases are increasing due to the adoption of alcohol, western lifestyle, smoking, and poor diet choice. Thus in turn propel the cancer segment growth.

Erythropoietin Drugs Market-Competitive Landscape:

The increasing demand for erythropoietin drugs thus increases the market growth globally. Additionally, market players are focusing on new product launches, partnerships, joint ventures, collaborations, and regional growth. Moreover, an increase in anemia in cancer patients boosted the erythropoietin drug market growth. Furthermore, strategies used by market players to strengthen and expand their business include R&D spending, mergers & acquisitions, and distribution channel development. For instance, in March 2022, Zydus Lifesciences a company received the new drug approval for Oxemia (Desidustat). Additionally, it is a first-of-its-kind oral treatment for anemia associated with chronic kidney disease(CKD), from the Drugs Controller General of India (DCGI).

Key features of the study:

This proposed research study on erythropoietin drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for erythropoietin drugs market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the erythropoietin drugs market.

Impact of COVID-19 on erythropoietin drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on erythropoietin drugs market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the erythropoietin drugs market, we have also included competitive landscape and key innovator analysis for the Erythropoietin Drugs Market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the erythropoietin drugs market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global erythropoietin drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ERYTHROPOIETIN DRUGS MARKET KEY PLAYERS

  • AstraZeneca (U.K.)
  • Lupin (India)
  • Bristol-Myers Squibb Company (U.S.)
  • Endo International plc (Ireland)
  • JCR Pharmaceuticals Co., Ltd (Japan)
  • Pfizer Inc (U.S.)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Sun Pharmaceutical Industries Ltd (India)
  • Dr. Reddy's Laboratories Ltd (India)
  • Mylan N.V. (U.S.)
  • Novartis AG (Switzerland)
  • Cipla Inc (India)
  • Shanghai Dahua Pharmaceutical Co., Ltd (China)

GLOBALERYTHROPOIETIN DRUGS MARKET, BY TYPE

  • Biologics
  • Biosimilars

GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY PRODUCT

  • Erythropoietin
  • Darbepoetin-alfa

GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY APPLICATION

  • Cancer
  • Renal Diseases
  • Neurology
  • Others

GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Erythropoietin Drugs Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Erythropoietin Drugs Market Snippet by Type
    • 2.1.2. Erythropoietin Drugs Market Snippet by Product
    • 2.1.3. Erythropoietin Drugs Market Snippet by Application
    • 2.1.4. Erythropoietin Drugs Market Snippet by Country
    • 2.1.5. Erythropoietin Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Erythropoietin Drugs Key Market Trends

  • 3.1. Erythropoietin Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Erythropoietin Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Erythropoietin Drugs Market Opportunities
  • 3.4. Erythropoietin Drugs Market Future Trends

4. Erythropoietin Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Erythropoietin Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Erythropoietin Drugs Market Landscape

  • 6.1. Erythropoietin Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Erythropoietin Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
    • 7.1.2. Biologics
    • 7.1.3. Biosimilars

8. Erythropoietin Drugs Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2022&2030 (%)
    • 8.1.2. Erythropoietin
    • 8.1.3. Darbepoetin-alfa

9. Erythropoietin Drugs Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 9.1.2. Cancer
    • 9.1.3. Renal Diseases
    • 9.1.4. Neurology
    • 9.1.5. Others

10. Erythropoietin Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Erythropoietin Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Erythropoietin Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Erythropoietin Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Erythropoietin Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Erythropoietin Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Erythropoietin Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca (U.K.)
    • 11.2.2. Lupin (India)
    • 11.2.3. Bristol-Myers Squibb Company (U.S.)
    • 11.2.4. Endo International plc (Ireland)
    • 11.2.5. JCR Pharmaceuticals Co., Ltd (Japan)
    • 11.2.6. Pfizer Inc (U.S.)
    • 11.2.7. Teva Pharmaceutical Industries Ltd (Israel)
    • 11.2.8. Sun Pharmaceutical Industries Ltd (India)
    • 11.2.9. Dr. Reddy's Laboratories Ltd (India)
    • 11.2.10. Mylan N.V. (U.S.)
    • 11.2.11. Novartis AG (Switzerland)
    • 11.2.12. Cipla Inc (India)
    • 11.2.13. Shanghai Dahua Pharmaceutical Co., Ltd (China)

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Erythropoietin Drugs Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Erythropoietin Drugs Market, by Type2018-2030 (USD Million)
  • TABLE Erythropoietin Drugs Market: ProductSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Erythropoietin Drugs Market, by Product2018-2030 (USD Million)
  • TABLE Erythropoietin Drugs Market: Regional snapshot (2022)
  • TABLE Erythropoietin Drugs Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Erythropoietin Drugs Market, by Application 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Erythropoietin Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Erythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE EuropeErythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Erythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Erythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Erythropoietin Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Erythropoietin Drugs Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Erythropoietin Drugs Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Erythropoietin Drugs Market, by Application, 2018-2030 (USD Million)